Y-mAbs Therapeutics, Inc.

YMAB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$67,234$78,637$105,762$181,564
Short-Term Investments$0$0$0$0
Receivables$19,688$22,454$12,531$7,712
Inventory$7,214$5,065$6,702$5,512
Other Curr. Assets$4,373$4,955$5,452$7,473
Total Curr. Assets$98,509$111,111$130,447$202,261
Property Plant & Equip (Net)$859$1,636$2,343$5,689
Goodwill$0$0$0$0
Intangibles$2,276$2,631$2,986$1,663
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$18,260$12,491$5,680$3,170
Total NC Assets$21,395$16,758$11,009$10,522
Other Assets$0$0$0$0
Total Assets$119,904$127,869$141,456$212,783
Liabilities
Payables$6,662$6,060$14,175$13,552
Short-Term Debt$630$1,804$868$1,783
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$16,406$12,264$13,241$12,540
Total Curr. Liab.$23,698$20,128$28,284$27,875
LT Debt$190$517$899$1,851
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,012$6,239$3,052$2,951
Total NC Liab.$4,202$6,756$3,951$4,802
Other Liabilities$0$0$0$0
Cap. Leases$820$1,419$1,767$3,634
Total Liabilities$27,900$26,884$32,235$32,677
Equity
Pref Stock$0$0$0$0
Common Stock$4$4$4$4
Retained Earnings-$487,136-$457,470-$436,043-$340,475
AOCI$2,264$449$1,331$1,371
Other Equity$576,872$558,002$543,929$519,206
Total Equity$92,004$100,985$109,221$180,106
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$119,904$127,869$141,456$212,783
Net Debt-$66,414-$76,316-$103,995-$177,930